Multiple Sclerosis: The Evidence-Based Supplement Protocol

← Back to articles

Multiple sclerosis is treated primarily with disease-modifying therapies (DMTs) — interferon beta, glatiramer, fingolimod, dimethyl fumarate, ocrelizumab, and others. Supplement evidence is narrow but real, dominated by vitamin D's strong cohort and trial data linking low 25-OH-D to MS risk and disease activity.

Vitamin D — Repletion to Serum 25-OH-D 40–60 ng/mL

Vitamin D has the strongest supplement evidence in MS. Multiple large cohort studies show inverse association between serum 25-OH-D and MS risk, relapse rate, and MRI activity. The 2018 Bhargava et al. RCT (the FORTE trial) showed high-dose D (10,400 IU/day) was safe and produced more favorable T-cell profiles than low-dose. The 2014 meta-analysis showed vitamin D supplementation modestly reduced relapse rate. Target 25-OH-D 40–60 ng/mL — most MS patients need 4,000–10,000 IU daily. See vitamin D piece.

Biotin — High-Dose MD1003 Controversial

High-dose biotin (300 mg/day, the MD1003 protocol) was tested in progressive MS in the 2016 MS-SPI trial showing a small functional improvement, but the larger SPI2 trial (2020) was negative. The intervention is not currently recommended in major guidelines. Standard-dose biotin offers nothing for MS. Note that high-dose biotin interferes with thyroid and other lab assays.

Omega-3 — Modest Cohort Signal, Mixed Trial Data

Omega-3 has modest signals in MS cohorts and a few small positive RCTs, though larger trials have been mixed. Reasonable adjunct for cardiovascular health regardless. See our omega-3 form review.

Vitamin B12 — Test and Replete

B12 deficiency can produce demyelination indistinguishable from MS plaques and frequently co-occurs. Annual serum B12 + MMA testing. Replete if low. See B12 form piece.

Lipoic Acid, 1,200 mg Daily

A 2017 RCT in 51 adults with secondary progressive MS showed alpha-lipoic acid 1,200 mg daily reduced brain volume loss by ~68% versus placebo over 2 years. The signal is intriguing but the trial is small; replication ongoing. See ALA piece.

What NOT to Take

Avoid echinacea, astragalus, and other "immune boost" herbals — MS is an autoimmune condition and immune activation may worsen disease. Avoid bee venom therapy and stem cell snake oil — no evidence, real risk. Don't replace DMTs with supplements alone — relapses cause irreversible disability. Skip "MS detox" protocols entirely. See caution list.

How to Run the Protocol

DMT first per neurology. Test 25-OH-D, B12, MMA at baseline. Vitamin D repletion to 40–60 ng/mL with ongoing 4,000–10,000 IU daily. Replete B12 if low. Add omega-3 2 g daily as a low-cost cardiovascular adjunct. Consider lipoic acid 1,200 mg daily in progressive MS, in consultation with neurology. See MS adjunct page.